Form 4: Waystar CBO Sells Shares After Option Exercise

Waystar Holding Corp.'s Chief Business Officer, Eric L. Sinclair III, exercised stock options and subsequently sold 9,701 shares of common stock on October 20, 2025, under a Rule 10b5-1 plan.

Summary

• Eric L. Sinclair III, Chief Business Officer of Waystar Holding Corp. (WAY), engaged in an insider transaction on October 20, 2025.
• Mr. Sinclair exercised 9,701 stock options at an exercise price of $4.14 per share.
• Concurrently, he sold 9,701 shares of common stock at a weighted average price of $36.9378 per share, with individual sales ranging from $36.52 to $37.86.
• These transactions were executed automatically pursuant to a Rule 10b5-1 plan adopted on February 19, 2025.
• Following these transactions, Mr. Sinclair beneficially owns 474,826 shares of common stock (including unvested RSUs) and 58,206 vested stock options.
• The exercised options were vested and have an expiration date of November 1, 2027.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the transaction was pre-planned under a Rule 10b5-1 plan, mitigating concerns about opportunistic selling. The significant profit realized by the insider is a positive for the individual, but the filing itself does not provide new information about the company's operational performance.

Positives

• The Chief Business Officer realized a significant profit from exercising options at $4.14 and selling shares at a weighted average of $36.9378, indicating a substantial increase in the company's stock value since the options were granted.
• The transaction was conducted under a pre-arranged Rule 10b5-1 plan, which suggests the sale was not based on immediate, non-public information.

Negatives

• Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake in the company.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reflects a routine insider transaction for liquidity or diversification purposes, common across all industries for executives with equity compensation. It does not provide specific insights into broader industry trends or competitive positioning for Waystar Holding Corp. within the healthcare technology sector.

Stakeholder Impact

• Shareholders: May perceive the insider sale as a slight negative signal, though the pre-arranged nature of the 10b5-1 plan typically lessens this impact. The transaction itself is a small fraction of the company's total outstanding shares.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

A single insider transaction, even involving a Chief Business Officer, especially when executed under a pre-arranged Rule 10b5-1 plan, typically does not warrant a change in investment recommendation without additional fundamental company news or broader market context. The transaction appears to be for personal financial planning rather than a signal about the company's immediate prospects. Investors should 'hold' and continue to monitor Waystar's operational performance and broader market conditions.

Keywords

Waystar Holding Corp., WAY, Insider Trading, Form 4, Stock Options, Rule 10b5-1 Plan, Chief Business Officer, Equity Sales, Beneficial Ownership